Global Drug Delivery Challenges Explained

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Global Drug Delivery Challenges Explained

Topic: Bio Break
YouTube video thumbnail

In this episode of Bio Break, Nick Allan and Nigel Syrotuck dive into the surprising realities of global drug delivery. While medical devices often dominate development conversations, the way drugs are delivered across regions can dramatically change how treatments succeed — or fail.

Nigel reflects on a trip to Italy where food sparked thoughts about oral drug delivery. In regions like Italy, pills and tablets are the most common approach. Larger countries also tend to prefer simple, scalable methods such as pills or injections. By contrast, smaller regions may be more open to specialized treatments that require more time or unique handling.

Regional Differences in Drug Delivery

Drug delivery methods are influenced not just by culture, but also by economics, insurance systems, and infrastructure. For example, biosimilars are more readily accepted in some countries depending on reimbursement structures. Meanwhile, large-scale programs — such as vaccine rollouts — highlight how fragile supply chains can be.

Cold Chain and Pandemic Lessons

Certain drugs, including attenuated vaccines, require strict cold chain maintenance. In developing regions, this presents a major challenge. The COVID-19 pandemic underscored this issue when millions of doses expired due to distribution and storage limitations. As Nick and Nigel note, a drug designed for one part of the world may face barriers to adoption in another, depending on the delivery method.

Rightness Trap Medtech concept showing a crossroads decision with opposing directional signs

Jason McGee explores how the Rightness Trap Medtech dynamic can quietly erode enterprise value in medical device companies.

Gram positive vs negative bacteria explained with diagram and comparison

Understanding gram positive vs negative bacteria is essential when studying sterility, microbiology, and antibiotic effectiveness. While many people think the difference is only about staining, the reality is much deeper.

Alcohol disrupting bacterial cell membrane explaining why 70 percent sanitizer kills bacteria more effectively

Nick and Nigel explore the science behind hand sanitizer formulations. They discuss how alcohol interacts with bacterial cells, why water improves its effectiveness, and what the additional ingredients in sanitizer actually do.

Scott Phillips of StarFish Medical and Peter van der Velden of Lumira Ventures speaking at a MedTech transactions webinar

Scott Phillips, CEO of StarFish Medical, sits down with Peter van der Velden, Managing General Partner at Lumira Ventures, to explore the strategic thinking behind major MedTech transactions and investments.